Motley Fool30d agobullish
3 "Magnificent Seven" Stocks Worth Buying Right NowThey've not been all that magnificent of late, but the sellers behind a few of their recent setbacks seem to have overshot their target.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
40last 24h
1793last 7d
300● bullish (7d)
170● bearish (7d)
205publishers
StockStory30d agobullish
UnitedHealth’s (NYSE:UNH) Q2 CY2026: Beats On Revenue, Stock SoarsHealth insurance company UnitedHealth (NYSE:UNH) announced better-than-expected revenue in Q2 CY2026, but sales were flat year on year at $112 billion. Its non-GAAP profit of $6.38 per share was 30.6% above analysts’ consensus estimates.
Simply Wall St.30d agobullish
Did Analyst Upgrades and Buybacks Just Shift Newmont's (NEM) Operational Efficiency Investment Narrative?In mid-July 2026, Newmont Corporation, the world’s largest gold miner, received multiple analyst upgrades highlighting improved operational efficiency, growing free cash flow and active share buybacks amid rising unit costs and ongoing integration of its Newcrest acquisition. These updates underline how Newmont’s efforts to streamline its portfolio and invest in lower-cost core assets are reshaping how analysts view the balance between its cost pressures and long-term gold exposure. We’ll...
The Wall Street Journal30d agobullish
🔎 Under the Radar: AtaiBeckley Stock Soars on Eli Lilly DealEli Lilly has struck a deal to buy mental-health-focused AtaiBeckley for an initial $2.8 billion, continuing a recent buying spree. Eli will pay $6.75 a share in cash for the biopharma company, a 26% premium to yesterday's closing price of $5.
Investing.com30d agobullish
GE Aerospace beats estimates, lifts guidance on services growthInvesting.com -- GE Aerospace reported second-quarter results that exceeded analyst expectations and raised its full-year outlook across all metrics, driven by robust commercial services growth.
Verdict30d agobullish
TCS opens industrial AI lab in Bengaluru in partnership with NvidiaThe AI lab will support rapid prototyping, validation, and scaling of industrial automation for enterprises in mobility and manufacturing.
Motley Fool30d agobullish
This Dividend ETF Has Outperformed Many Actively Managed Funds Over 10 YearsThe First Trust Rising Dividend Achievers ETF has a performance history that rivals any dividend ETF available today.
Proactive30d agobullish
Citi starts Hikma at 'buy' with strategy reset offering compelling entry pointCiti has initiated coverage of Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) with a 'buy' rating and a £17 price target, arguing the generic drugmaker's current valuation offers a compelling entry point. The 12-month target, based on a sum-of-the-parts valuation, implies a share price return...
Investor's Business Daily30d agobullish
UNH Stock Flashes Buy Signal On Massive Earnings BeatUnitedHealth Group crushed Q2 earnings forecasts amid lower-than-expected benefit costs and gave a big boost to its full-year outlook. Humana, Centene and CVS Health all got a sizable lift from the warm reception for UnitedHealth's earnings report.
StockStory30d agobullish
1 Cash-Heavy Stock on Our Buy List and 2 We Turn DownCompanies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits, making them unattractive borrowers.
Motley Fool30d agobullish
RWR vs. GQRE: Which REIT ETF Is the Better Buy for Income Investors?RWR offers lower fees and boasts stronger one-year returns, while GQRE offers global diversification and a higher dividend yield.
Investing.com30d agobullish
UnitedHealth shares surge on strong earnings beat and guidanceInvesting.com -- UnitedHealth Group (NYSE:UNH) reported second quarter results that exceeded analyst expectations across earnings, revenue and guidance, sending shares up 7% premarket as investors responded positively to the healthcare giant's improved outlook.
InvestorsHub30d agobullish
Uber agrees to buy Delivery Hero in $14.8 billion deal to expand global food delivery business (UBER)Uber Technologies (NYSE:UBER) has reached an agreement to acquire Germany’s Delivery Hero (TG:DHER) in a transaction valued at approximately $14. 8 billion, strengthening its international food delivery operations as competition across the sector continues to intensify.
StockStory30d agobullish
3 Market-Beating Stocks for Long-Term InvestorsThe best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends of the investing world.
Reuters Videos30d agobullishVIDEO
AI Weekly: SK Hynix shares jump up and down, Apple sues OpenAI<body><p>STORY: From SK Hynix shares yo-yoing to Apple suing OpenAI...</p><p>This is AI Weekly.</p><p>:: AI Weekly</p><p>SK Hynix shares went on a wild ride after its U.S. listing last week.</p><p>Shares plunged 15% in trading on Monday, marking the South Korean chip giant's biggest one-day fall on record.</p><p>But the firm's stock bounced back almost 13% later in the week.</p><p>It followed gains made in U.S. tech stocks after softer-than-expected U.S. inflation data and upbeat analyst forecasts for AI memory demand.</p><p>Meta plans to produce AI chips this September.</p><p>That's according to a memo seen by Reuters.</p><p>The move would help Meta gain more independence from chip suppliers like Nvidia.</p><p>Apple sued OpenAI and two former employees.</p><p>The U.S. tech giant alleged misappropriation of its trade secrets to benefit the ChatGPT-maker's move into consumer hardware.</p><p>It accused OpenAI of orchestrating an effort to acquire and exploit Apple's confidential information through former employees, recruiting practices and supplier relations.</p><p>OpenAI said in a statement they "have no interest in other companies’ trade secrets."</p><p>IBM shares plunged by a quarter in one day.</p><p>Investors sold off after the U.S. tech company signaled the AI infrastructure boom has drawn spending away from the software sector.</p><p>IBM said it expected revenue to rise just 1% in the second quarter, falling short of Wall Street hopes.</p><p>The announcement added to worries over a software industry already rocked by the rise of AI tools.</p><p>And TSMC raised it forecast for capital spending by up to 14% for this year.</p><p>It comes after the chipmaker and major Nvidia supplier posted a 77% jump in second-quarter profit of $22 billion.</p><p>That was well ahead of market forecasts and the firm's ninth straight quarter of double-digit percentage growth.</p><p>Looking ahead, capital expenditure for this year is forecast to now be between $60 billion and $64 billion.</p></body>
Motley Fool30d agobullish
SpaceX vs. Rocket Lab: Which Is the Better Space Stock to Buy Right Now?Rocket stocks have been on a wild ride lately.
InvestorsHub30d agobullish
AtaiBeckley shares soar on reports of potential Eli Lilly takeover talks (ATAI)AtaiBeckley (NASDAQ:ATAI) shares jumped as much as 53% in premarket trading on Thursday after reports emerged that Eli Lilly (NYSE:LLY) is in discussions to acquire the psychedelic drug developer. Potential deal would broaden Lilly’s neuroscience portfolioAccording to BMO Capital Markets analyst Evan David Seigerman, an acquisition of AtaiBeckley would strengthen Eli Lilly’s presence in psychiatry while supporting its strategy of expanding beyond its established cardiometabolic business.
Barrons.com30d agobullish
J.B. Hunt Stock Jumps as Earnings Exceed High Expectations for TruckingWednesday, J.B. Hunt reported earnings per share of $1.91, up 45% year over year, from sales of $3.5 billion, up 19%.
Motley Fool30d agobullish
Does Palantir's Latest Partnership With Nvidia Make It a Screaming Buy?Nvidia and Palantir are partnering up for sovereign AI.
Investor's Business Daily30d agobullish
Taiwan Semiconductor Tops Q2 Targets On Leading-Edge Chip DemandTaiwan Semiconductor Manufacturing beat analyst estimates for the second quarter and with its outlook. But TSM stock fell.
Barrons.com30d agobullish
This Psychedelic Pharma Stock Is Soaring 50% on Report of Eli Lilly Takeover TalksPsychedelic drugmaker AtaiBeckley was surging 50% ahead of the open Thursday following a report that pharma giant Eli Lilly is nearing a deal to buy the company . A deal, being negotiated at a premium, could be announced as early as this week, Bloomberg reported, citing people familiar with the matter. The shares jumped 22% in a single day in April when President Donald Trump signed a directive to accelerate the Food and Drug Administration’s review of psychedelic drugs for serious mental illnesses.
BioPharma Dive30d agobullish
Merck wins first approval of a PCSK9 cholesterol pillThe speedy clearance of Lipfendra is an important milestone for Merck and the result of a controversial voucher program put in place by former commissioner Marty Makary.
StockStory30d agobullish
1 Cash-Producing Stock on Our Buy List and 2 That UnderwhelmGenerating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Retail Insight Network30d agobullish
Uber Eats expands retail offering with GameStop partnershipThe collaboration allows customers to have video games, consoles, accessories, collectibles and other electronics delivered from GameStop stores across the US.
Reuters30d agobullish
Space startup funding holds near record highs as SpaceX IPO draws new investorsBy Akash Sriram July 16 (Reuters) - Global investment in space startups was near record levels in the second quarter, buoyed by investor enthusiasm following SpaceX's nearly $86 billion initial public
Offshore Technology30d agobullish
Halliburton wins unconventional gas project contract from AramcoThe contract is part of a multibillion-dollar agreement connected to one of the world’s largest unconventional gas development initiatives.